4Africa Fernandez-L, Paul A Northcott, Michael D Taylor, et al. Normal and oncogenic roles for miRNAs in the de- veloping brain [ J ]. Cell Cycle, 2009,8 ( 24 ) :4049 - 4054.
5Griffiths-Jones S, Grocock R J, van Dongen S, et al. miR- Base:microRNA sequences, targets and gene nomenclature [ J ]. Nucleic Acids Res, 2006, 34 ( Database issue) : 140 - 144.
6Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for annotation, visualization, and integrated dis- covery [ J ]. Genome Biol,2003,4 (5): 3.
7Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioin- formatics Resources [ J ]. Nature Protoc, 2009,4 ( 1 ) : 44 -57.
8Medina PP, Slack FJ. miRNAs and cancer: an overview [ J ]. Cell Cycle, 2008, 7 (16) :2485 - 2492.
9Sorrentino A, Liu CG, Addario A, et al. Role of miRNAs in drug-resistant ovarian cancer cells [ J ]. Gynecol Oncol, 2008,111 (3) :478 - 486.
10Hummel R, Hussey D J, Haier J. miRNAs: Predictors and modifiers of chemo-and radiotherapy in different tumour types[J]. Eur J Cancer, 2010, 46(2) :298 -311.